179 related articles for article (PubMed ID: 18705225)
1. Rituximab in treating refractory thrombotic thrombocytopenic purpura: three case reports.
Dalia S; McNulty B; Colvin GA
Med Health R I; 2008 Jul; 91(7):226-8. PubMed ID: 18705225
[No Abstract] [Full Text] [Related]
2. Anti-CD20 antibody in thrombotic thrombocytopenic purpura refractory to plasma exchange.
Chow KV; Carroll R; Branley P; Nicholls K; Becker G; Hogan C
Intern Med J; 2007 May; 37(5):329-32. PubMed ID: 17504282
[TBL] [Abstract][Full Text] [Related]
3. Long-term remission in a patient with refractory thrombotic thrombocytopenic purpura treated with rituximab and plasma exchange.
Basquiera AL; Damonte JC; Abichaín P; Sturich AG; García JJ
Ann Hematol; 2008 Apr; 87(4):321-3. PubMed ID: 17899079
[No Abstract] [Full Text] [Related]
4. Spotlight on rituximab as a new therapeutic option for dermatomyositis and thrombotic thrombocytopenic purpura.
Ferrer E; Moral MA
Drug News Perspect; 2006 Oct; 19(8):482-4. PubMed ID: 17160148
[TBL] [Abstract][Full Text] [Related]
5. Rituximab treatment of thrombotic thrombocytopenic purpura in the setting of connective tissue disease.
Niewold TB; Alpert D; Scanzello CR; Paget SA
J Rheumatol; 2006 Jun; 33(6):1194-6. PubMed ID: 16755668
[TBL] [Abstract][Full Text] [Related]
6. Timing of plasma exchange and rituximab for the treatment of thrombotic thrombocytopenic purpura.
Boctor FN; Smith JA
Am J Clin Pathol; 2006 Dec; 126(6):965; author reply 965-6. PubMed ID: 17153777
[No Abstract] [Full Text] [Related]
7. The management of thrombotic thrombocytopenic purpura in 2005.
Rock G
Semin Thromb Hemost; 2005 Dec; 31(6):709-16. PubMed ID: 16388422
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and safety of first-line rituximab in severe, acquired thrombotic thrombocytopenic purpura with a suboptimal response to plasma exchange. Experience of the French Thrombotic Microangiopathies Reference Center.
Froissart A; Buffet M; Veyradier A; Poullin P; Provôt F; Malot S; Schwarzinger M; Galicier L; Vanhille P; Vernant JP; Bordessoule D; Guidet B; Azoulay E; Mariotte E; Rondeau E; Mira JP; Wynckel A; Clabault K; Choukroun G; Presne C; Pourrat J; Hamidou M; Coppo P;
Crit Care Med; 2012 Jan; 40(1):104-11. PubMed ID: 21926591
[TBL] [Abstract][Full Text] [Related]
9. Successful treatment of severe thrombotic thrombocytopenic purpura with the monoclonal antibody rituximab.
Chemnitz J; Draube A; Scheid C; Staib P; Schulz A; Diehl V; Söhngen D
Am J Hematol; 2002 Oct; 71(2):105-8. PubMed ID: 12353309
[TBL] [Abstract][Full Text] [Related]
10. Rituximab treatment for thrombotic thrombocytopenic purpura associated with human immunodeficiency virus failing extensive treatment with plasma exchange: a report of two cases.
Evans MW; Vaughan LB; Giffi VS; Zimrin AB; Hess JR
AIDS Patient Care STDS; 2010 Jun; 24(6):349-52. PubMed ID: 20515417
[TBL] [Abstract][Full Text] [Related]
11. A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.
Ozdogu H; Boga C; Kizilkilic E; Yeral M; Kozanoglu I; Karatas M
J Thromb Thrombolysis; 2007 Apr; 23(2):147-50. PubMed ID: 17221322
[TBL] [Abstract][Full Text] [Related]
12. Effectiveness of rituximab as prophylaxis in thrombotic thrombocytopenic purpura.
Benetatos L; Vassou A; Bourantas KL
Clin Lab Haematol; 2006 Aug; 28(4):288-9. PubMed ID: 16898975
[No Abstract] [Full Text] [Related]
13. Another beneficial effect of rituximab on refractory and relapsing thrombotic thrombocytopenic purpura: the role of interleukin-12 suppression?
Park SJ; Shin JI
Crit Care Med; 2012 Apr; 40(4):1391. PubMed ID: 22425862
[No Abstract] [Full Text] [Related]
14. Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.
Patino W; Sarode R
J Clin Apher; 2007 Feb; 22(1):17-20. PubMed ID: 17285618
[TBL] [Abstract][Full Text] [Related]
15. Long-term follow-up of idiopathic thrombotic thrombocytopenic purpura treated with rituximab.
Chemnitz JM; Uener J; Hallek M; Scheid C
Ann Hematol; 2010 Oct; 89(10):1029-33. PubMed ID: 20422413
[TBL] [Abstract][Full Text] [Related]
16. Caplacizumab Therapy without Plasma Exchange for Acquired Thrombotic Thrombocytopenic Purpura.
Chander DP; Loch MM; Cataland SR; George JN
N Engl J Med; 2019 Jul; 381(1):92-94. PubMed ID: 31269374
[No Abstract] [Full Text] [Related]
17. Rituximab for the treatment of thrombotic thrombocytopenic purpura in systemic lupus erythematosus.
Limal N; Cacoub P; Sène D; Guichard I; Piette JC
Lupus; 2008 Jan; 17(1):69-71. PubMed ID: 18089688
[No Abstract] [Full Text] [Related]
18. Successful remission of thrombotic thrombocytopenic purpura with rituximab in a patient with undifferentiated connective tissue disorder.
Gupta D; Roppelt H; Bowers B; Kunz D; Natarajan M; Gruber B
J Clin Rheumatol; 2008 Apr; 14(2):94-6. PubMed ID: 18391679
[TBL] [Abstract][Full Text] [Related]
19. A new treatment for TTP?
Fakhouri F; Deroure B; Hummel A
Nephrol Dial Transplant; 2006 Mar; 21(3):577-9. PubMed ID: 16401622
[No Abstract] [Full Text] [Related]
20. Cardiogenic shock complicates successful treatment of refractory thrombotic thrombocytopenia purpura with rituximab.
Millward PM; Bandarenko N; Chang PP; Stagg KF; Afenyi-Annan A; Hay SN; Brecher ME
Transfusion; 2005 Sep; 45(9):1481-6. PubMed ID: 16131381
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
